Related Experiment Video
Updated: Jun 17, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Dramatic complete response in patient with lung adenocarcinoma
Sara Serrano Solares1, Dolores Isla Casado, María Jesús Vidal Losada
1Servicio de Oncología Médica, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. sarusky_zgz@hotmail.com
Summary
New treatments are improving outcomes for non-small-cell lung cancer (NSCLC). Maintenance therapy led to a complete response in a patient with stage IV NSCLC and bone metastases.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Non-small-cell lung cancer (NSCLC) historically has a poor prognosis, particularly in advanced stages.
- Stage IV NSCLC with bone metastases presents significant therapeutic challenges.
- The evolving landscape of cancer treatment includes targeted therapies and novel maintenance strategies.
Observation:
- A patient diagnosed with stage IV non-small-cell lung cancer presented with bone metastases.
- The patient received maintenance treatment following initial therapy.
Findings:
- Maintenance treatment resulted in a dramatic complete response in this patient.
- This outcome highlights the potential efficacy of ongoing therapeutic strategies in advanced NSCLC.
Implications:
- Maintenance therapy may represent a crucial strategy for improving outcomes in non-small-cell lung cancer.
- Further research into maintenance treatment protocols could redefine treatment paradigms for stage IV NSCLC.
- Achieving complete response in metastatic NSCLC underscores the progress in systemic therapies.
